Category Archive: Tracks

Jun 13

Building a Biotech Business: The Big Picture & The Nitty Gritty

Campbell Alliance Deal Makers Intention Survey Thursday June 13th from 10:15am-11:30am Following a highly successful Super Session at the BIO International Convention, Campbell Alliance is pleased to present the results of its fifth annual Dealmakers’ Intentions Survey, the only forward-looking measure of deal-making activity in the pharmaceutical and biotech industries. While there are many quality …

Continue reading »

Jun 13

The Future, 2030

The year is 2030 and biotechnology is recognized as one of humankind’s greatest intellectual enterprises. Cancer is a manageable disease and world hunger has largely been alleviated. The life sciences industry has been an investment hub for private and public investors for more than a decade and public opinion on biotechnology is at an all-time …

Continue reading »

Jun 13

The Future of Healthcare: It’s Digital, It’s Connected and It’s Consumer-Driven

A look at the Future of Digital Connected Health and Wellness Care Thursday June 13th from 10:15am-11:30am To set the stage for the rest of the track, our experts will address a range of topics to help us look at the future of digital health and wellness care from a scientific, technical, and consumer perspective. …

Continue reading »

Jun 13

Capital Case Studies

Finding the Money: Where to Look and What Sells Thursday June 13th from 11:45am-1:00pm There’s money available for new and cash hungry private companies who know where to look and bring the right investment proposition, but it’s not going to be easy or quick. Get the scoop on who is investing or re-investing, how much …

Continue reading »

Jun 13

Life Science Speed Dating: Finding the Diamond Ring from VC and Pharma

Pharmaceutical Business Development Investing Thursday June 13th from 10:15am-11:30am Moderator: Brian O’Callaghan, President & CEO, Sangart Confirmed Panelists: Adam Keeney, VP, Head of Transactions, Johnson & Johnson West Coast Innovation Centers John McDonald, Vice President, Co-Head of Business Development and Mergers & Acquisitions, Biogen Idec Lisa Mendoza, Associate Director, Bayer Healthcare John Tupman, Vice President, …

Continue reading »